Results 141 to 150 of about 135,393 (265)
ABSTRACT Background Patients with recurrent head and neck cancer (HNC) often present with severe, persistent dysphagia and xerostomia following prior chemoradiation. Although swallowing impairments and salivary dysfunction have been reported in this population, prior longitudinal studies have not examined changes in salivary composition or how these ...
Jenni Wu +8 more
wiley +1 more source
Submucosal-Predominant (Inverted-Type) Pyloric Gland Adenoma of the Duodenum Mimicking Malignancy. [PDF]
Alp J +4 more
europepmc +1 more source
Distinct O-Linked Glycosylation Systems in Signaling and Immune Regulation. [PDF]
Wang S, Xiao S, Huang Y, Wang X.
europepmc +1 more source
Mucin armoured diethylaminoethyl-dextran cloaked rebamipide based oral nanoformulation for the therapy of inflammatory bowel disease. [PDF]
Jori C +5 more
europepmc +1 more source
Cellulose-Based Polymer Blends for Oral Mucoadhesion: Impact of Hydration and Surface Interactions. [PDF]
Rojewska M +6 more
europepmc +1 more source
Cutaneous Focal Mucinosis Successfully Treated With Superpulsed Carbon Dioxide Laser. [PDF]
Hekmat M +3 more
europepmc +1 more source
With the advantages of high‐resolution imaging, efficient image acquisition, intraoperative real‐time detection, and radiation‐free and noninvasive characteristics, optical coherence tomography (OCT) provides accurate diagnosis and effective intraoperative guidance for the minimally invasive diagnosis and treatment of central nervous system (CNS ...
Jiuhong Li +10 more
wiley +1 more source
Endobiliary radiofrequency ablation for refractory cholangitis caused by mucin-producing intraductal papillary neoplasm of the bile duct. [PDF]
Urata T, Ueno S, Kajiwara M.
europepmc +1 more source
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg +9 more
wiley +1 more source

